Do you want to read an article? Please log in or register.
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)
COVID-19
Related content
RECOMMENDED
COVID-19
Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
★ 2
Recommended by
Alexander Meisel, Faculty Member
Eur J Cancer.
Giesen N, Sprute R, Rüthrich M, Khodamoradi Y, Mellinghoff SC, Beutel G, Lueck C, Koldehoff M, Hentrich M, Sandherr M, von Bergwelt-Baildon M, Wolf HH, Hirsch HH, Wörmann B, Cornely OA, Köhler P, Schalk E, von Lilienfeld-Toal M
doi: 10.1016/j.ejca.2020.09.009.Visit the original publication at ncbi.nlm.nih.gov
COVID-19
Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement
CA Cancer J Clin.
Lenihan D, Carver J, Porter C, Liu JE, Dent S, Thavendiranathan P, Mitchell JD, Nohria A, Fradley MG, Pusic I, Stockerl-Goldstein K, Blaes A, Lyon AR, Ganatra S, López-Fernández T, O'Quinn R, Minotti G, Szmit S, Cardinale D, Alvarez-Cardona J, Curigliano G, Neilan TG, Herrmann J
doi: 10.3322/caac.21635.
COVID-19
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)
Eur J Cancer
Lièvre A, Turpin A, Ray-Coquard I, Le Malicot K, Thariat J, Ahle G, Neuzillet C, Paoletti X, Bouché O, Aldabbagh K, Michel P, Debieuvre D, Canellas A, Wislez M, Laurent L, Mabro M, Colle R, Hardy-Bessard AC, Mansi L, Colomba E, Bourhis J, Gorphe P, Pointreau Y, Idbaih A, Ursu R, Di Stefano AL, Zalcman G, Aparicio T, GCO-002 CACOVID-19 collaborators/investigators.
doi: 10.1016/j.ejca.2020.09.035
Further PublicationsCOVID-19
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)
Eur J Cancer.
Lièvre A, Turpin A, Ray-Coquard I, Le Malicot K, Thariat J, Ahle G, Neuzillet C, Paoletti X, Bouché O, Aldabbagh K, Michel P, Debieuvre D, Canellas A, Wislez M, Laurent L, Mabro M, Colle R, Hardy-Bessard AC, Mansi L, Colomba E, Bourhis J, Gorphe P, Pointreau Y, Idbaih A, Ursu R, Di Stefano AL, Zalcman G, Aparicio T, GCO-002 CACOVID-19 collaborators/investigators.
doi: 10.1016/j.ejca.2020.09.035.
RECOMMENDED
Breast Cancer
Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline
★ 1
Recommended by
Dr Andreas Müller, Faculty Member
★ 1
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
doi: 10.1200/JCO.20.00299.
Further Publications
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study
Eur J Cancer.
de Joode K, Dumoulin DW, Tol J, Westgeest HM, Beerepoot LV, van den Berkmortel FWPJ, Mutsaers PGNJ, van Diemen NGJ, Visser OJ, Oomen-de Hoop E, Bloemendal HJ, van Laarhoven HWM, Hendriks LEL, Haanen JBAG, de Vries EGE, Dingemans AC, van der Veldt AAM, DOCC Investigators.
doi: 10.1016/j.ejca.2020.09.027.
COVID-19
Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence
Ecancermedicalscience.
Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, Van Hemelrijck M
doi: 10.3332/ecancer.2020.1022.
Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment
JAMA Oncol.
Abid MB, Mughal M, Abid MA
doi: 10.1001/jamaoncol.2020.2367.
Gynecologic Cancer
European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer
Int J Gynecol Cancer.
Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F, Mahner S, Mahantshetty U, Mirza M, Petersen C, Querleu D, Regauer S, Rob L, Rouzier R, Ulrikh E, van der Velden J, Vergote I, Woelber L, van der Zee AGJ
doi: 10.1097/